Main description:

The book Coronavirus Therapeutics Volume I provides the most comprehensive review on contemporary knowledge on the origin and structural biology and molecular aspects of Coronaviruses. This also describes the etiology and pathogeny and therapeutic targets including vaccine drug candidates against Coronaviruses in the light of current scientific knowledge. Using an integrative approach to the understanding of Coronaviruses structure, function and immunobiology, the contributors provide a synopsis of novel mechanisms by which Coronaviruses can be treated.

Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.

Contents:

1. Origin and structural biology of Novel Coronavirus (SARS-CoV-2). Rahul Mallick, University of Eastern Finland and Asim K. Duttaroy, University of Oslo.
2. The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2. Muhammad Munir, Lancaster University, UK. (CTP)3. Epidemiology, transmission and molecular immunopathology of SARS-CoV-2. Rahul Mallick, University of Eastern Finland and Asim K. Duttaroy, University of Oslo.4. Epidemiology and Etiopathogeny of Covid-19. Modesto Leite Rolim Neto, School of Medicine, Universidade Federal do Cariri, Brasil.5. Immunological and Hematological Response in COVID-19. Mariusz Kowalewski. Central Clinical Hospital of the Ministry of Interior and Administration. Warsaw, Poland.6. Toll-like receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective. Suprabhat Mukherjee. Kazi Nazrul University, India.7. Potential drug strategies to target Coronaviruses. Kasturi Sarkar and Parames C. Sil1. Division of Molecular Medicine. Bose Institute. India. 8. Possible therapeutic intervention strategies for COVID-19 by manipulating the cellular proteostasis network. Koyeli Mapa. Department of Life Sciences, Shiv Nadar University, India. 9. The potential impact of statins in the treatment of patients with COVID-19 infection. Amir Avan. Mashhad University of Medical Sciences, Mashhad, Iran. 10. Anticoronavirus activity of water-soluble pristine C60 fullerenes: in vitro and in silico screening. Uwe Ritter. National University of Kyiv, Kyiv, Ukraine. 11. Application of Nanoscale materials and nanotechnology against viral infection: A special focus on Coronaviruses. Subhankar Paul. Institute of Technology Rourkela, Orissa, India. 12. Obesity: A Risk Factor for Covid-19 - Geetha Suryakumar, Defence Institute of Physiology and Allied Sciences, India.13. Cytokine Storm and Failed Resolution in COVID-19: Taking Cue from Multiple Sclerosis. Shailendra Giri. Henry Ford Hospital, USA.